Could a simple gel soothe heartburn without drugs? new trial aims to find out

NCT ID NCT07624383

Recruiting now Symptom relief Sponsor: Cellmedis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a new medical device that forms a protective barrier in the esophagus to reduce heartburn and other GERD symptoms. Fifty adults with non-erosive GERD will take the device or a placebo four times daily for two weeks, then switch. The goal is to see if it relieves symptoms and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: alginate-based esophageal barrier medical device
What this could lead to: If it works, this could offer a new, non-drug option for people with GERD to manage their symptoms.
What could go wrong: This is a small, early-stage trial with only 50 participants. The device may not work better than placebo, and results may not apply to everyone with GERD.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease Heartburn Laryngopharyngeal Reflux Non-Erosive Reflux Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GERD (GASTROESOPHAGEAL REFLUX DISEASE) HEARTBURN NERD REGURGITATION, GASTRIC

Contacts and locations

Locations

Medical Network
RECRUITING

Warsaw, Masovian Voivodeship, 04-501, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.